We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+24.19%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$136M
AUM Growth
+$21.9M
Cap. Flow
-$8.36M
Cap. Flow %
-6.13%
Top 10 Hldgs %
68.06%
Holding
58
New
8
Increased
12
Reduced
7
Closed
22

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$1.34M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.29M
3
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$943K
4
KIN
Kindred Biosciences, Inc.
KIN
+$596K
5
DGX icon
Quest Diagnostics
DGX
+$593K

Top Sells

Rank Stock Value
1
GIVN
GIVEN IMAGING LTD
GIVN
+$2.57M
2
HUM icon
Humana
HUM
+$1.87M
3
SLTM
SOLTA MED INC (DE)
SLTM
+$1.85M
4
AGN
Allergan plc
AGN
+$1.8M
5
ELV icon
Elevance Health
ELV
+$1.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.3%
2 Healthcare 38.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLTI
51
CALL
DELISTED
QLT Inc
QLTI
– –
-16,500
Closed -$76K
XNPT
52
CALL
DELISTED
XENOPORT, INC.
XNPT
– –
-50,000
Closed -$284K
AUXL
53
PUT
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-100,000
Closed -$1.82M
GIVN
54
DELISTED
GIVEN IMAGING LTD
GIVN
– –
-109,950
Closed -$2.57M
VPHM
55
PUT
DELISTED
VIROPHARMA INC
VPHM
– –
-50,000
Closed -$1.96M
SLTM
56
DELISTED
SOLTA MED INC (DE)
SLTM
– –
-892,250
Closed -$1.85M
VVUS
57
PUT
DELISTED
Vivus Inc
VVUS
– –
-15,000
Closed -$1.4M
ANAC
58
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
-37,730
Closed -$401K
1 2
3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Healthcare Value Capital held 58 positions worth $136M, up 19% from $114M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Healthcare Value Capital withdrew a net $8.36M in Q4 2013, closing 22 positions and reducing 7 holdings. Its most notable exit was GIVEN IMAGING LTD, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 57% a quarter earlier, followed by Healthcare.

Against the trend, Healthcare Value Capital opened a new position in Baxter International worth $1.39M.

  • Healthcare Value Capital's largest Q4 2013 buy was Baxter International: 36,820 shares worth $1.39M.
  • Healthcare Value Capital added most to Supernus Pharmaceuticals in Q4 2013, an estimated $1.29M increase.
  • Healthcare Value Capital's biggest Q4 2013 reduction was ANI Pharmaceuticals, cutting an estimated $890K.
  • Healthcare Value Capital fully exited GIVEN IMAGING LTD in Q4 2013, selling an estimated $2.57M.
  • Healthcare Value Capital's ten largest holdings make up 68% of its $136M portfolio in Q4 2013.
  • Healthcare Value Capital opened 8 new positions and closed 22 in Q4 2013.
  • Healthcare Value Capital's portfolio value rose 19% quarter-over-quarter to $136M.

Based on Healthcare Value Capital's 13F filing for Q4 2013, filed 13 Feb 2014.